Treatment of Nocturnal Asthma

$39.50 plus tax (Refund Policy)

Buy Article:

Abstract:

Extensive work has been done over the past decade to determine the best drug regimen for the treatment of nocturnal asthma. Much of the work has been directed at the evaluation of theophylline preparations and  sympathomimetic agents. With a better understanding of the mechanisms causing nocturnal asthma, future therapeutic advances will be targeted at the underlying pathophysiological causes of the disorder. This article wilt review current treatment modalities, including those shown to have some effect as welt as those that have no benefit.

Document Type: Research Article

DOI: http://dx.doi.org/10.2500/108854193778816798

Publication date: January 1, 1993

More about this publication?
  • Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.

    The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma.

    Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.

    Articles marked "F" offer free full text for personal noncommercial use only.

    The journal is indexed in Thomson Reuters Web of Science and Science Citation Index Expanded, plus the National Library of Medicine's PubMed service.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Information for Advertisers
  • Reprint Requests
  • ingentaconnect is not responsible for the content or availability of external websites
Related content

Tools

Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more